Ticagrelor: all 294 studies that test it
Page 2 of 3. Open to participants first (27), then studies with results posted, then the rest; newest registration first within each.
- A Study to Investigate the Effect of Oral Ticagrelor on the Pharmacokinetics of Oral Rosuvastatin When Given in Healthy ParticipantsCompletedNCT06554821Phase 1
- TADCLOT- a Double Blind Randomized Controlled TrialCompletedNCT06318481Phase 3
- Ticagrelor With Aspirin Dual Antiplatelet Therapy Combined With Intravenous Thrombolysis for Ischemic StrokeCompletedNCT06316570Phase 3
- Ticagrelor Versus Clopidogrel in Large Vessel Ischemic StrokeCompletedNCT06120725Phase 3
- Ticagrelor vs. Clopidogrel in Post PCI PatientsCompletedNCT05858918Not applicable
- De-escalation of Ticagrelor in Post PPCIStatus unknownNCT05831462Phase 1/2
- Effects of Ticagrelor Versus Prasugrel on Coronary Microcirculation in Patients Undergoing Elective Percutaneous Coronary Intervention: Results of the PROtecting MICROcirculation During Coronary Angioplasty (PROMICRO)-3 Randomised StudyCompletedNCT05643586Phase 4
- Ticagrelor Versus Clopidogrel in Ischemic StrokeCompletedNCT05553613Phase 3
- Impact of CYP2C19 Genotype-guided Clopidogrel and Ticagrelor Treatment on Platelet Function Test and Metabolomics ProfileCompletedNCT05516784Phase 4
- Testing P2Y12 Platelet Inhibitors Generics Beyond BioequivalenceCompletedNCT05474053Phase 3
- KF2019#1-trial: Effects of a Thrombocyte Inhibitor on a Cholesterol-lowering DrugStatus unknownNCT05373277Phase 1
- Platelet Aggregation and Adenosine Levels Among Patients Taking Ticagrelor or PrasugrelCompletedNCT05247385Phase 4
- Optimal Dosage of Ticagrelor in Korean Patients With AMIStatus unknownNCT05210595Phase 4
- Dual Antiplatelet Therapy in Patients With Clopidogrel Resistance Following Off-Pump Coronary Artery BypassStatus unknownNCT05166538Phase 4
- Ticagrelor Monotherapy After StentingCompletedNCT05149560Phase 2
- Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular AtherostenosisActive, not recruitingNCT05047172Phase 3
- 1-month DAPT Plus 5-month Ticagrelor Monotherapy Versus 12-month DAPT in Patients With Drug-coated BalloonActive, not recruitingNCT04971356Not applicable
- Comparison of the Efficacy of Ticagrelor Combined With ASA to ASA Alone in Patients With StrokeCompletedNCT04962451Phase 4
- Ticagrelor in Post-transplant Patients With Pediatric Hepatic Artery Thrombosis (HAT)Status unknownNCT04946929Phase 3
- Optical Coherence Tomography-Guided PCI With Single-Antiplatelet TherapyCompletedNCT04766437Phase 2
- Platelet Inhibition With Ticagrelor 60 mg Versus Ticagrelor 90 mg in Elderly Patients With ACSCompletedNCT04739384Phase 3
- Efficacy of Ticagrelor Plus Aspirin in Mild Non-cardioembolic Ischemic StrokeCompletedNCT04738097Phase 3
- Evaluation of Safety and Efficacy of Two Ticagrelor-based De-escalation Antiplatelet Strategies in Acute Coronary SyndromeStatus unknownNCT04718025Phase 3
- Dual Therapy With Dabigatran/Ticagrelor Versus Dual Therapy With Dabigatran/Clopidogrel in ACS Patients With Indication for NOAC Undergoing PCIStatus unknownNCT04688723Phase 4
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of AZD3366 in Healthy Subjects, Japanese and Chinese SubjectsCompletedNCT04588727Phase 1
- Efficacy and Safety of Individualized P2Y12 Receptor Antagonists Treatment Based on Agregometry Versus Fixed Dose Regimen in Patients After Acute Myocardial InfarctionCompletedNCT04369534Phase 4
- Optimized Antiplatelet Therapy on the Prognosis of ACS Patients With Non-predominant Coronary Artery Disease After PCIStatus unknownNCT04338919Not applicable
- Platelet REACtivity According to TICagrelor Dose After Transcatheter AorticValve ImplantationCompletedNCT04331145Phase 4
- A sTudy of Low Dose vs Standard Dose of tIcaGrelor on Platelet Function After intErvention for Acute Coronary syndRome in Diabetes Mellitus PatientsStatus unknownNCT04307511Phase 4
- Study to Evaluate the Effect of Ticagrelor Versus Placebo in Reducing Vaso-Occlusive Crises Rate in Pediatric Patients With Sickle Cell Disease.WithdrawnNCT04293172Phase 3
- The Effects of loW Dose tIcagrelor on Platelet Function Testing in Patients With Stable Coronary arTery DiseaseCompletedNCT04206176Phase 1/2
- Ticagrelor in Remote Ischemic Preconditioning StudyCompletedNCT04174261Phase 4
- Safety and Effectiveness of Ticagrelor in Patients Undergoing Carotid StentingStatus unknownNCT04091074Phase 1
- Clopidogrel With Aspirin in High-risk Patients With Acute Non-disabling Cerebrovascular Events IICompletedNCT04078737Phase 3
- Study in Diabetes Mellitus Patients Without Prior Myocardial Infarction or Stroke Undergoing Elective Percutaneous Coronary Intervention.WithdrawnNCT04069234Phase 3
- LOwer Maintenance Dose TICagrelor in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary InterventionStatus unknownNCT04060914Phase 4
- Ticagrelor Compared to Clopidogrel in Acute Coronary SyndromesCompletedNCT04057300Phase 4
- DUAL Antithrombotic Therapy in Patients With AF and ACSStatus unknownNCT04023630Phase 4
- Ticagrelor and Clopidogrel on Platelet Effects in Chinese Patients With Stable Coronary Artery DiseaseCompletedNCT04001894Phase 4
- Ticagrelol Versus Aspirin in Ischemic StrokeCompletedNCT03884530Phase 3
- Ticagrelor Monotherapy Compared to Aspirin Monotherapy in Patients With History of ACSCompletedNCT03881943Phase 4
- Personalization of Long-Term Antiplatelet Therapy - RAPID EXTENDTerminatedNCT03729401Phase 4
- Low-dose of Ticagrelor and Standard-dose Clopidogrel on Platelet Effects in Chinese Patients With Stable CAD.CompletedNCT03679091Phase 4
- Efficacy and Safety of Low Dose Ticagrelor in Patients With Unstable Angina Pectoris After Coronary Stent ImplantationStatus unknownNCT03620760Phase 4
- Ticagrelor and Clopidogrel on Platelet Aggregation in Clopidogrel Resistance's Patients With CHDStatus unknownNCT03614832Phase 4
- The Optimal Strategy of Switching From Clopidogrel to Ticagrelor in Patients With Complexity of Coronary Artery DiseaseCompletedNCT03577652Not applicable
- Ticagrelor and ASA vs. ASA Only After Isolated Coronary Artery Bypass Grafting in Patients With Acute Coronary SyndromeActive, not recruitingNCT03560310Phase 4
- PK Study of Ticagrelor in Children Aged Less Than 24 Months, With Sickle Cell Disease (HESTIA4)CompletedNCT03492931Phase 1
- Anti-platelet Therapy in the Prevention of Cardiovascular Disease in Patients With COPD (APPLE-COPD: ICON 2)CompletedNCT03487406Phase 2
- A Study of the Effect of Epinephrine on Platelet Reactivity in Subjects Treated With TicagrelorCompletedNCT03441412Phase 1
- Prasugrel vs. Ticagrelor on Myocardial Injury in STEMICompletedNCT03435133Not applicable
- A Study to Investigate the Interaction Between ACT-246475 and Clopidogrel, Prasugrel, and Ticagrelor in Healthy SubjectsCompletedNCT03430661Phase 1
- Low Dose Ticagrelor Versus Low Dose Prasugrel in Patients With Prior Myocardial InfarctionCompletedNCT03387826Phase 4
- TicagRelor Or Clopidogrel in Severe and Terminal Chronic Kidney Disease Patients Undergoing PERcutaneous Coronary Intervention for an Acute Coronary Syndrome.CompletedNCT03357874Phase 3
- The Safety and Efficacy Of Rivaroxaban and Ticagrelor for Patients With Atrial Fibrillation After Percutaneous Coronary InterventionCompletedNCT03331484Phase 3
- Effectiveness of Lower Maintenance Dose of Ticagrelor Early After Myocardial Infarction (ELECTRA) Pilot StudyCompletedNCT03251859Phase 3
- Study Comparing Treatment Effectiveness of Guideline Indicated APT for ACS in Patients With CKDStatus unknownNCT03150667Phase 4
- TIMES: Ticagrelor vs. Placebo/ Clopidogrel With Aspirin in Anterior STEMI Patients Treated With Primary PCIStatus unknownNCT03145194Phase 2
- A Study to Compare if the Uptake of Ticagrelor in the Body Differs When Different Tablets Are AdministeredCompletedNCT03126695Phase 1
- The Impact of Genotype on Pharmacokinetics and Antiplatelet Effects of Ticagrelor in Healthy ChineseCompletedNCT03092076Phase 1
- Ticagrelor Versus High-dose Clopidogrel in Patients With High Platelet Reactivity on Clopidogrel After PCIWithdrawnNCT03078465Phase 3
- Half-dose Ticagrelor Overcomes High-dose Clopidogrel in Acute Coronary Syndrome Patients With High On-Clopidogrel Platelet ReactivityStatus unknownNCT03062462Phase 2/3
- Platelet Aggregation in Patients With Coronary Artery Disease and Kidney Dysfunction Taking Clopidogrel or TicagrelorCompletedNCT03039205Phase 2
- A Single Center Study to Evaluate Ticagrelor Mechanism of Action in Inhibiting Juvenile Platelet ADP ResponseWithdrawnNCT03027934Phase 4
- Reversal of the Antiplatelet Effects of Ticagrelor in Combination With Aspirin, Using Normal PlateletsStatus unknownNCT03005704Not applicable
- A Trial to Assess the Safety and Efficacy of Prophylactic TicagrelOr With Acetylsalicylic Acid Versus CLopidogrel With Acetylsalicylic Acid in the Development of Cerebrovascular EMbolic Events During TAVICompletedNCT02989558Phase 3
- Half Dose of Prasugrel and Ticagrelor in Acute Coronary Syndrome (HOPE-TAILOR)CompletedNCT02944123Phase 3
- Influence of Naloxone on Ticagrelor Pharmacokinetics and Pharmacodynamics in Patients With Unstable Angina Pectoris on Concomitant Treatment With MorphineCompletedNCT02939248Phase 4
- Influence of Metoclopramide on Ticagrelor Pharmacokinetics and Pharmacodynamics in Patients With Unstable Angina Pectoris on Concomitant Treatment With MorphineCompletedNCT02939235Phase 4
- Effects of Different Doses of Ticagrelor on Platelet Aggregation and Endothelial Function in Diabetic Patients With Stable Coronary Artery DiseaseStatus unknownNCT02889549Phase 2/3
- Comparison of Prasugrel and Ticagrelor in the Treatment of Acute Myocardial InfarctionCompletedNCT02808767Phase 4
- Effects of Ticagrelor on No-reflow in Patients With Acute ST-segment Elevation Myocardial InfarctionStatus unknownNCT02798874Not applicable
- Ticagrelor Versus Clopidogrel in Myocardial Salvage in Patients With STEMI Undergoing Primary PCIStatus unknownNCT02792712Phase 4
- The Success of Opening Single CTO Lesions to Improve Myocardial Viability Study (SOS-comedy)CompletedNCT02767401Phase 4
- Post-operative Treatment of Diabetic Peripheral Arterial Disease Guided by Platelet Reactivity UnitStatus unknownNCT02762864Not applicable
- Platelet Inhibition of Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients After Elective Percutaneous Coronary InterventionCompletedNCT02748330Phase 4
- High On-treatment Platelet Reactivity Identified by Multiple Platelet Function AssayCompletedNCT02699008Not applicable
- Ticagrelor Versus Clopidogrel in Carotid Artery StentingCompletedNCT02677545Phase 2
- Ticagrelor vs Clopidogrel for Platelet Inhibition in Stenting for Cerebral AneurysmCompletedNCT02675205Phase 3
- A Randomized, Pharmacodynamic Comparison of Low Dose Ticagrelor to Clopidogrel in Patients With Prior Myocardial InfarctionCompletedNCT02663713Phase 4
- Rapid P2Y12 Receptor Inhibition Attenuates Inflammatory Cell Infiltration in Thrombus Aspirated From the STEMI PatientsCompletedNCT02639143Phase 4
- The Effect of Ticagrelor on 15-Epi-Lipoxin A4 and InflammationWithdrawnNCT02626169Phase 4
- Comparing Ticagrelor Versus Clopidogrel on MicrocirculationCompletedNCT02618733Not applicable
- Assessment of Loading With the P2Y12 Inhibitor Ticagrelor or Clopidogrel to Halt Ischemic Events in Patients Undergoing Elective Coronary StentingCompletedNCT02617290Phase 3
- Ticagrelor in Human Endotoxemia Response to Human EndotoxemiaCompletedNCT02612480Not applicable
- Comparison of Administration Strategies of Ticagrelor in Patients With Unstable Angina Pectoris, a Pharmacokinetic / Pharmacodynamic StudyCompletedNCT02612116Phase 4
- Hunting for the Off-Target Properties of Ticagrelor on Endothelial Function in Humans (HI-TECH)CompletedNCT02587260Phase 4
- The Effect of Ticagrelor or Clopidogrel on Endothelial Function During Acute and Chronic TreatmentCompletedNCT02580149Phase 4
- COmparison of the Pharmacodynamics and Pharmacokinetics Ticagrelor Versus Clopidogrel in Patients With CKD and NSTE-ACSStatus unknownNCT02578537Phase 4
- ComparisoN of ticAgrelor vs. Clopidogrel in endoTHeliAl Function of COPD patieNtsCompletedNCT02519608Phase 2
- Safety and Efficacy of Low-dose Ticagrelor in Chinese Patients With Stable Coronary Artery DiseaseStatus unknownNCT02514642Phase 4
- Evaluation of Antiplatelet Effects and Safety of Intraoperative Administration of Ticagrelor Versus ClopidogrelStatus unknownNCT02513004Phase 4
- Ticagrelor vs. Prasugrel Effects on Infarct SizeWithdrawnNCT02507323Phase 2
- Platelet Reactivity in Acute Non-disabling Cerebrovascular EventsCompletedNCT02506140Phase 2/3
- TIcagrelor in Rotational Atherectomy to Reduce TROPonin EnhancementCompletedNCT02505399Phase 4
- Ticagrelor Monotherapy After 3 Months in the Patients Treated With New Generation Sirolimus Stent for Acute Coronary Syndrome (TICO Study)Status unknownNCT02494895Phase 4
- Comparison of Ticagrelor vs. Prasugrel on Inflammation, Arterial Stiffness, Endothelial Function, and Circulating Endothelial Progenitor Cells in Diabetic Patients With Non-ST Elevation Acute Coronary Syndrome (NSTE-ACS) Requiring Coronary StentingCompletedNCT02487732Phase 4
- Peripheral Endothelial Function Assessment of Patients on Ticagrelor vs. Clopidogrel Who Have Undergone PCICompletedNCT02469740Phase 4
- Comparison of TIcagrelor and Clopidogrel in Patients With Coronary Artery diseaSe and Type 2 Diabetes Mellitus (TICS-DM)Status unknownNCT02457130Phase 4
- Dose Adaptation to Offset the Interaction Between Ticagrelor and Ritonavir by Population-based PK ModelingCompletedNCT02435563Phase 2